1492 Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.77M Sell
153,700
-14,058
-8% -$333K 1.44% 26
2025
Q4
$4.16M Buy
+167,758
New +$4.45M 1.59% 25
2025
Q2
Sell
-26,860
Closed -$833K 128
2025
Q1
$833K Buy
26,860
+3
+0% +$100 0.45% 61
2024
Q4
$847K Buy
+26,857
New +$1.28M 0.4% 64

Other funds holding ASTH

1492 Capital Management's ASTH Position: Q1 2026 in Review

1492 Capital Management reduced its Astrana Health (ASTH) stake by 8.4% in Q1 2026, selling an estimated $333K and leaving 153,700 shares worth $3.77M. The position accounts for 1.44% of the portfolio, ranked #26.

1492 Capital Management first reported a position in ASTH in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.16M in Q4 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • 1492 Capital Management held 153,700 shares of Astrana Health worth $3.77M as of Q1 2026.
  • 1492 Capital Management sold 14,058 Astrana Health shares in Q1 2026, an estimated $333K.
  • Astrana Health made up 1.44% of 1492 Capital Management's portfolio in Q1 2026, its #26 holding.
  • 1492 Capital Management first reported a position in Astrana Health in Q4 2024 and has held it in 4 quarters since.
  • 1492 Capital Management's Astrana Health position peaked at $4.16M in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on 1492 Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.